Macrogenics Inc (NASDAQ: MGNX) is -45.23% lower on its value in year-to-date trading and has touched a low of $0.99 and a high of $5.77 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MGNX stock was last observed hovering at around $1.64 in the last trading session, with the day’s gains setting it 0.14%.
Currently trading at $1.78, the stock is 16.21% and 21.55% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 25.58 million and changing 8.54% at the moment leaves the stock -35.27% off its SMA200. MGNX registered -61.88% loss for a year compared to 6-month loss of -47.49%. The firm has a 50-day simple moving average (SMA 50) of $1.4644 and a 200-day simple moving average (SMA200) of $2.749975.
The stock witnessed a 24.48% gain in the last 1 month and extending the period to 3 months gives it a -22.27%, and is 17.88% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.82% over the week and 6.45% over the month.
Macrogenics Inc (MGNX) has around 341 employees, a market worth around $112.30M and $154.05M in sales. Profit margin for the company is -36.23%. Distance from 52-week low is 79.86% and -69.15% from its 52-week high. The company has generated returns on investments over the last 12 months (-50.18%).
with sales reaching $16.74M over the same period.The EPS is expected to shrink by -71.96% this year, but quarterly earnings will post -45.73% year-over-year. Quarterly sales are estimated to grow 55.05% in year-over-year returns.
Macrogenics Inc (MGNX) Top Institutional Holders
169.0 institutions hold shares in Macrogenics Inc (MGNX), with institutional investors hold 92.38% of the company’s shares. The shares outstanding are 63.09M, and float is at 57.94M with Short Float at 10.52%. Institutions hold 89.59% of the Float.
The top institutional shareholder in the company is BELLEVUE GROUP AG with over 9.94 million shares valued at $42.25 million. The investor’s holdings represent 15.8662% of the MGNX Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 6.0 million shares valued at $25.5 million to account for 9.5749 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 5.4 million shares representing 8.6202% and valued at over $22.96 million, while VANGUARD GROUP INC holds 6.5992 of the shares totaling 4.14 million with a market value of $17.58 million.
Macrogenics Inc (MGNX) Insider Activity
The most recent transaction is an insider sale by Smith Beth Ann, the company’s VP, Controller & Treasurer. SEC filings show that Smith Beth Ann sold 423 shares of the company’s common stock on Feb 15 ’25 at a price of $2.56 per share for a total of $1083.0. Following the sale, the insider now owns 9532.0 shares.
